Use of intratympanic dexamethasone for the therapy of low frequency hearing loss. (Q50448277)

14 March 2018

title

Use of intratympanic dexamethasone for the therapy of low frequency hearing loss. (English)

1 reference

14 March 2018

1 reference

1 reference

Necat Alatas

1

1 reference

14 March 2018

publication date

20 December 2008

1 reference

14 March 2018

European Archives of Oto-Rhino-Laryngology

published in

1 reference

14 March 2018

volume

266

1 reference

14 March 2018

issue

8

1 reference

14 March 2018

page(s)

1205-1212

1 reference

14 March 2018

https://scigraph.springernature.com/pub.10.1007/s00405-008-0895-2

exact match

0 references

cites work

Clinical observations on acute low-tone sensorineural hearing loss. Survey and analysis of 137 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Is corticosteroid therapy effective for sudden-onset sensorineural hearing loss at lower frequencies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Acute low-tone sensorineural hearing loss without vertigo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Oral Steroid Treatment of Sudden Sensorineural Hearing Loss: A Ten Year Retrospective Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Short-term outcome and prognosis of acute low-tone sensorineural hearing loss by administration of steroid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Oral steroid regimens for idiopathic sudden sensorineural hearing loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Natural history of sudden sensorineural hearing loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Permeability of the round window membrane for prednisolone-21-hydrogen succinate. Prednisolone content of the perilymph after local administration vs. systemic injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Three Cases of Cochleosaccular Endolymphatic Hydrops without Vertigo Revealed by Furosemide-Loading Vestibular Evoked Myogenic Potential Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Effectiveness of treatment for sudden sensorineural hearing loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Chemical perfusion of the inner ear.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Intratympanic dexamethasone injection effects on transient-evoked otoacoustic emission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

[Prognostic criteria in sudden deafness]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

Distribution of HRP in the inner ear after injection into the middle ear cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-008-0895-2

The use of systemic steroids in otolaryngology.

21 January 2018

1 reference

12 December 2020

Localization, frequency, and severity of endolymphatic hydrops and the pathology of the labyrinthine membrane in Menière's disease

1 reference

12 December 2020

Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study

1 reference

12 December 2020

Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report).

1 reference

12 December 2020

Sudden hearing loss: eight years' experience and suggested prognostic table

1 reference

12 December 2020

The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study.

1 reference

12 December 2020

Steroid use in idiopathic sudden sensorineural hearing loss.

1 reference

12 December 2020

Prognosis and treatment of sudden sensorineural hearing loss.

1 reference

12 December 2020

10.1007/S00405-008-0895-2

Identifiers

DOI

1 reference

14 March 2018

PubMed ID

19099315

1 reference

14 March 2018